Follow this page and receive
notifications about new suppliers
Dabigatran etexilate API Manufacturers
compare suppliers & get competitive offers
Date | Seller | Exporter country | Buyer | Importer country | Product | Quantity (KG) | Price per KG | Latest transactions |
---|---|---|---|---|---|---|---|---|
30-Sep-2024 | (Hidden) | India | ADAMED PHA... | Poland | DABIGATRAN... | 44.93 | $ @36$-7! | Check all data |
30-Sep-2024 | (Hidden) | India | ADAMED PHA... | Poland | DABIGATRAN... | 47.14 | $ @36$-7! | |
27-Sep-2024 | (Hidden) | India | GEDEON RIC... | Hungary | DABIGATRAN... | 471.30 | $ @36$-7! |
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Producer
Produced in:
Established in: 2018
MOQ: -
Employees: 200+
WHO GMP Approved sites for production
25+ years experience in manufacturing APIs for regulated markets
High quality product & superior client service
+ 0
All certificates
Distributor
Produced in:
Established in: 1994
MOQ: -
Employees: 50+
26+ years of distribution expertise with regulatory excellence
16 worldwide locations supplying high quality ingredients
All our manufacturer partners are cGMP complaint
+ 0
All certificates
Producer
Established for 17 years and a leading enterprise in China's API industry
Mature technology and advanced production equipment
Quality assurance and fast delivery
+ 0
All certificates
Distributor
Produced in:
Established in: 1987
MOQ: -
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 37 years
+ 0
All certificates
Producer
Produced in:
Established in: 2019
MOQ: 1 g
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1944
MOQ: -
Employees: 4,000
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
+ 0
All certificates
Producer
Produced in:
Established in: 1994
MOQ: -
Employees: 4,000
All our 5 plants are top notch and FDA approved
We are a backwards integrated company
We have received 24 CEP’s and 27 USDMF’s
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
Produced in:
Established in: 1995
MOQ: -
Employees: 10000
Fermentation technology Experts
Partnerships with 1200 pharma companies in 100+ countries
US FDA, EMA, COFEPRIES, ANVISA, PMDA accreditations
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Dabigatran etexilate API 211915-06-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Dabigatran etexilate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Dabigatran etexilate
- Synonyms:
- Dabigatran
- Cas Number:
- 211915-06-9
- DrugBank number:
- DB06695
- Unique Ingredient Identifier:
- 2E18WX195X
About Dabigatran etexilate
Here you will find more information about Dabigatran etexilate. Dabigatran etexilate is an oral prodrug that is hydrolyzed to the competitive and reversible direct thrombin inhibitor dabigatran. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients in whom anticoagulation therapy is indicated5. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary5. Dabigatran etexilate was approved by the FDA in 20106.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Dabigatran etexilate is a type of Direct thrombin inhibitors
Direct thrombin inhibitors are a crucial subcategory of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a vital role in anticoagulation therapy. These inhibitors are specifically designed to target and inhibit the activity of thrombin, a key enzyme involved in the blood clotting process.
Thrombin is responsible for converting fibrinogen into fibrin, the insoluble protein that forms the backbone of blood clots. By directly inhibiting thrombin, these APIs prevent the formation of blood clots, making them highly effective in the prevention and treatment of thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and stroke.
Direct thrombin inhibitors offer several advantages over traditional anticoagulants. Unlike heparin and warfarin, which target multiple coagulation factors, these inhibitors act specifically on thrombin, leading to a more predictable anticoagulant effect. Moreover, they have a rapid onset of action and do not require routine monitoring or frequent dosage adjustments.
Some commonly used direct thrombin inhibitors include dabigatran, argatroban, and bivalirudin. These APIs are typically administered orally or intravenously, depending on the specific clinical scenario. However, it is crucial to note that the use of direct thrombin inhibitors requires careful patient selection and monitoring, as they may increase the risk of bleeding.
In conclusion, direct thrombin inhibitors represent an important subcategory of pharmaceutical APIs that provide targeted and effective anticoagulation therapy. Their specific mechanism of action and favorable pharmacokinetic profiles make them valuable tools in the management of thromboembolic disorders, improving patient outcomes and reducing the risk of complications.
Dabigatran etexilate (Direct thrombin inhibitors), classified under Anticoagulants
Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.
There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.
Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.
While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.
In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.
Dabigatran etexilate manufacturers | traders | suppliers
We have 22 companies offering Dabigatran etexilate produced in 5 different countries.
Get in contact with the supplier of your choice:
- Gonane Pharma from India, product country of origin India
- Rochem International, Inc. from United States, product country of origin United States
- Xi'an ZB Biotech Co., Ltd from China, product country of origin China
- Sinoway industrial Co.,Ltd from China, product country of origin China
- Apino Pharma Co., Ltd. from China, product country of origin China
- Dr. Reddy's from India, product country of origin India
- Apotex Pharmachem from India, product country of origin India
- Menovo from China, product country of origin China
- Teva API from Israel, product country of origin Unknown
- Vasudha Pharma Chem Ltd. from India, product country of origin India
- Qilu Antibiotics from China, product country of origin China
- Solfyn International LLP from India, product country of origin India
- Biocon from India, product country of origin India
- Intas Pharma from United Kingdom, product country of origin Unknown
- Boehringer Ingelheim from Germany, product country of origin Germany
- Micro Labs from India, product country of origin India
- Sun Pharma from India, product country of origin India
- Hetero Drugs from India, product country of origin India
- Piramal Pharma Solutions from India, product country of origin India
- Optimus Drugs Pvt Ltd from India, product country of origin India
- Lupin from India, product country of origin India
- MSN Labs. from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.